New Technologies & Molecules: Ready for the Future of Biologics Manufacturing?
Andre L. Walker, CPIP
If you want to prepare yourself for the next 10 years of your career, then I invite you to join me at this year's 2018 ISPE Biopharmaceutical Manufacturing Conference, 10 -12 December, Huntington Beach, California, a conference focused on a fascinating and challenging future that is just around the corner. Our theme says it all…..
New Technologies and Molecules - Are You Ready for the Future of Biologics Manufacturing?
We’ve brought together regulators and practitioners who are meeting the challenge of industrializing personalized medicine, expanding into Oligonucleotides and ADC’s, and charting the path to Continuous Biomanufacturing. Register now to learn and network with these industry and regulatory leaders who are on the forefront of this transformation.
As novel therapies emerge from the clinic and provide dramatic improvement in disease treatment, the biopharmaceutical professional of today must be prepared to design, build, operate, and support the new and different facilities and processes required to meet demand. To twist a phrase, “This won’t be your parents biopharm plant”
If you’ve started on this journey, then come share and compare experiences with our talented speaker panels during Q&A and networking sessions, take new information away, and help your peers learn from your experiences.
An all-star line-up of manufacturers leading the industry into the future including speakers from Kite, Biogen, Alnylam, Bluebird Bio, Medimmune, Genentech, Immunogen, and many more….
Access to global industry leaders and regulators – This event provides unique access not only to the representatives from these leading manufacturers, but also to FDA regulators and keynote speakers who set policy and direction for the industry.
An interactive, half-day workshop ‘from Lab to GMP Production’, led by experts in this emerging field – Collaborate with peers to design a facility and equipment layout that supports a new Cell Therapy treatment.
I hope you will join me in California this December as we explore, strategize, develop tools, and determine how to navigate the evolving technical and regulatory complexities of biopharm’s exciting future. Register now to learn and network with industry, academic researchers and regulatory leaders who are on the forefront of this transformation.
I’m from the past, but to some degree, we all are. A number of years ago, I received my Bachelor’s degree in mechanical engineering and a desire to make the world a better place. I joined the pharmaceutical industry with that goal in mind. 30 years later, I have that same desire, but the industry...
Featured in this edition of the Pharmaceutical Engineering® Online Reading Roundup are Online Exclusives. These are PE articles published exclusively on the website; you can always find them here. Here is a selection from the first two years of Online Exclusives on sustainability, drug shortages,...
Continuous Bioprocessing Platform Continuous processing is not new to the pharmaceutical industry. Today, the majority of major pharmaceutical companies at least consider continuous processes when developing new small-molecule entities. In contrast, the biopharmaceutical industry has been slow to...